Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-24-000010
Filing Date
2024-01-22
Accepted
2024-01-22 15:55:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2879
  Complete submission text file 0001949846-24-000010.txt   4273
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
HERSHBERG ROBERT (Reporting) CIK: 0001274139 (see all company filings)

Type: 144

Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41365 | Film No.: 24548825
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)